Results 111 to 120 of about 22,257 (214)

Coxitis in early axial spondyloarthritis

open access: yesСовременная ревматология, 2019
In Russia, coxitis is one of the most common extra-axial manifestations of ankylosing spondylitis (AS). However, many issues regarding its early diagnosis remain unresolved.Objective: to compare the clinical manifestations of coxitis with the data from ...
E. M. Agafonova   +5 more
doaj   +1 more source

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

open access: yesImmunoTargets and Therapy, 2021
Fabiola Atzeni,1 Antonio Carriero,2,3 Laura Boccassini,4 Salvatore D’Angelo2 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; 2Rheumatology Institute of Lucania (IReL), Rheumatology ...
Atzeni F   +3 more
doaj  

Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement

open access: yesСовременная ревматология
Objective: To analyze clinical and imaging characteristics of patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) with spinal involvement (axial PsA, axPsA) and to develop principles for the differential diagnosis between axPsA ...
E. E. Gubar   +13 more
doaj   +1 more source

Unmet Needs in Spondyloarthritis: Imaging in Axial Spondyloarthritis

open access: yesThe Journal of Rheumatology
Imaging biomarkers in axial spondyloarthritis (axSpA) are currently the most specific biomarkers for the diagnosis of this condition. Despite advances in imaging, from plain radiographs—which detect only damage—to magnetic resonance imaging (MRI)—which identifies disease activity and structural change—there are still many challenges that remain ...
Lianne S. Gensler   +3 more
openaire   +2 more sources

Higher body mass index and anti-drug antibodies predict the discontinuation of anti-TNF agents in Korean patients with axial spondyloarthritis

open access: yesRevista Brasileira de Reumatologia
Objective: The development of anti-drug antibodies against tumor necrosis factor inhibitors is a likely explanation for the failure of TNF-inhibitors in patients with spondyloarthritis.
Jiwon Hwang   +7 more
doaj   +1 more source

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.

open access: yesPLoS ONE, 2019
ObjectivesTo compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage.MethodsPatients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial ...
Monika Hebeisen   +8 more
doaj   +1 more source

Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?

open access: yesAdvances in Rheumatology
Background Spondyloarthritis (SpA) encompasses a spectrum of immune-mediated inflammatory conditions primarily affecting the axial skeleton, including sacroiliitis and spondylitis, each with distinct features.
Gabriel Caetano Pereira   +5 more
doaj   +1 more source

South African Rheumatism and Arthritis Association 2024 guidelines for the management of peripheral spondyloarthritis

open access: yesSouth African Medical Journal
Peripheral spondyloarthritis (SpA) includes psoriatic arthritis (PsA), inflammatory bowel disease (IBD)-associated arthritis, reactive arthritis and undifferentiated peripheral SpA.
R Benitha   +7 more
doaj   +1 more source

Rheumatoid arthritis and spondyloarthropathy [PDF]

open access: yes, 2013
Part 2 of the article can be found through this link: https://www.um.edu.mt/library/oar//handle/123456789/13280Rheumatoid arthritis (RA) and spondyloarthropathy are two groups of inflammatory joint disease.
Vassallo, Pierre
core  

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

open access: yes, 2020
Bathon, J.   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy